Hepatic Differentiated Embryo-chondrocyte-expressed Gene 1 (Dec1) Inhibits Sterol Regulatory Element-binding Protein-1c (Srebp-1c) Expression and Alleviates Fatty Liver Phenotype
Overview
Authors
Affiliations
Hepatic steatosis, characterized by ectopic hepatic triglyceride accumulation, is considered as the early manifestation of non-alcoholic fatty liver diseases (NAFLD). Increased SREBP-1c level and activity contribute to excessive hepatic triglyceride accumulation in NAFLD patients; however, negative regulators of Srebp-1c are not well defined. In this study, we show that Dec1, a critical regulator of circadian rhythm, negatively regulates hepatic Srebp-1c expression. Hepatic Dec1 expression levels are markedly decreased in NAFLD mouse models. Restored Dec1 gene expression levels in NAFLD mouse livers decreased the expression of Srebp-1c and lipogenic genes, subsequently ameliorating the fatty liver phenotype. Conversely, knockdown of Dec1 expression by an adenovirus expressing Dec1-specific shRNA led to an increase in hepatic TG content in normal mouse livers. Correspondingly, expression levels of lipogenic genes, including Srebp-1c, Fas, and Acc, were increased in livers of mice with Dec1 knockdown. Moreover, a functional lipogenesis assay suggested that Dec1 overexpression repressed lipid synthesis in primary hepatocytes. Finally, a luciferase reporter gene assay indicates that DEC1 inhibits Srebp-1c gene transcription via the E-box mapped to the promoter region. Chromatin immunoprecipitation confirmed that DEC1 proteins bound to the identified E-box element. Our studies indicate that DEC1 is an important regulator of Srebp-1c expression and links circadian rhythm to hepatic lipogenesis. Activation of Dec1 can alleviate the nonalcoholic fatty liver phenotype.
Tian Y, Gong J, He Z, Peng S, Huan Y, Cao H Sci Rep. 2025; 15(1):2340.
PMID: 39833384 PMC: 11747403. DOI: 10.1038/s41598-025-86596-6.
Circadian Regulation of Lipid Metabolism during Pregnancy.
Luo Y, Meng X, Cui L, Wang S Int J Mol Sci. 2024; 25(21).
PMID: 39519044 PMC: 11545986. DOI: 10.3390/ijms252111491.
Cheng Z, Liu B, Liu X Front Nutr. 2024; 11:1407265.
PMID: 39351493 PMC: 11439728. DOI: 10.3389/fnut.2024.1407265.
Zhang L, Chen J, Yang X, Shen C, Huang J, Zhang D Signal Transduct Target Ther. 2024; 9(1):20.
PMID: 38263084 PMC: 10806020. DOI: 10.1038/s41392-023-01727-7.
JY062 Alleviates Glucolipid Metabolism Disorders via the Adipoinsular Axis and Gut Microbiota.
Su Y, Ren J, Zhang J, Zheng J, Zhang Q, Tian Y Nutrients. 2024; 16(2).
PMID: 38257160 PMC: 10819581. DOI: 10.3390/nu16020267.